Working in Uganda to defeat Kaposi sarcoma worldwide – The Uganda Cancer Institute (UCI) and Fred Hutch have launched the UCI/Hutchinson Center Cancer Alliance, a partnership that is working to defeat Kaposi sarcoma and other infection-related cancers. The partnership has led to the first comprehensive cancer center jointly built by U.S. and African Cancer institutions in the sub-Saharan Africa — UCI-Fred Hutch Cancer Centre opened May 2015.
Uganda has one of the world’s highest concentrations of infection-related cancers, including Kaposi sarcoma. This makes it an ideal place for the Hutch to rapidly develop and introduce new diagnostic procedures and treatments. And it enables our researchers to collect data from a large number of patients at a single site—something that would be impossible in the developed world, where infection-related cancers are dispersed across huge areas.
The research is focused on identifying infectious diseases that cause cancer, develop ways to prevent or cure these diseases, and training a new generation of oncologists to care for patients in low-resource areas.
Learn more about our global oncology program >
Investigating innovative new treatments – Dr. Corey Casper and colleagues are investigating new treatments for Kaposi sarcoma as one of eight core sites of the NCI-sponsored AIDS Malignancy Consortium. For more information, please see the AMC website.